A clinico-genomic analysis of soft tissue sarcoma patients reveals CDKN2A deletion as a biomarker for poor prognosis

ConclusionOur clinico-genomic profiling of STS shows thatCDKN2A deletion was the most prevalent DNA copy number aberration and was associated with poor prognosis.
Source: Clinical Sarcoma Research - Category: Cancer & Oncology Source Type: research